SAGE PRO

Home / Research / Data Patterns (India) Ltd.

SAGE PRO · ORIGINAL EQUITY RESEARCH

Data Patterns (India) Ltd. — Q2 FY27 Results Analysis

Quarterly revenue

Published · Quarter Q2 FY27 · DATAPATTNS

PeriodQ2 FY27
COMPANY-SPECIFIC GRAPHICAL SUMMARY

What the reported figures reveal

CHART 1

Quarterly revenue

Q2 FY26₹3,075 million
Q1 FY27₹1,160 million
Q2 FY27₹1,332 million
CHART 2

Quarterly EBITDA

Q2 FY26₹685 million
Q1 FY27₹314 million
Q2 FY27₹314 million
CHART 3

Quarterly net profit

Q2 FY26₹492 million
Q1 FY27₹221 million
Q2 FY27₹220 million
CHART 4

H1 revenue

H1 FY26₹4,068 million
H1 FY27₹2,493 million
ORIGINAL RESEARCH INSIGHTS

Investment findings and watch points

RESEARCH INSIGHT

Quarterly revenue

Revenue recognition depends on customer milestones.

Watch: Monitor the next disclosed reporting period against the labelled comparison.

RESEARCH INSIGHT

Quarterly EBITDA

Profit recovery must accompany delivery.

Watch: Monitor the next disclosed reporting period against the labelled comparison.

RESEARCH INSIGHT

Quarterly net profit

Order conversion needs cash collection.

Watch: Monitor the next disclosed reporting period against the labelled comparison.

RESEARCH INSIGHT

H1 revenue

Revenue recognition depends on customer milestones.

Watch: Monitor the next disclosed reporting period against the labelled comparison.

FULL PUBLISHED RESEARCH

Earnings and management commentary analysis

Quarter ended September 30, 2026. Investment stance: WATCH. Figures are company-reported; ₹ crore and ₹ million are labelled separately. [S1] [S2]

1. Investment decision: strong orders, weak reported earnings

Data Patterns (India) is moving toward larger, more integrated defence-electronics contracts, but the September 2026 quarter shows how uneven that transition can be. Revenue fell 56.7% year on year to ₹133.2 crore, while orders received in the quarter rose from ₹167.1 crore to ₹929.1 crore. These numbers describe different stages of the business: contracts awarded today may take several quarters to become delivered systems and recognized sales.

The immediate investment question is whether the company can convert its enlarged order book into revenue without sacrificing its historically high margins or tying up too much cash. Management retained FY27 guidance of 20–25% revenue growth and 35–40% EBITDA margin, even though H1 revenue was ₹249.3 crore, down 38.7% year on year. That requires a much stronger second half; the guidance is management's expectation, not a completed result.

A valuation case needs the latest share price, diluted share count, a comparable earnings base and a defensible estimate of sustainable annual free cash flow. None is supplied by these two documents in a way that permits a dated market valuation. The investment stance is WATCH: stronger orders support the medium-term opportunity, while the gap between order announcements and recognized earnings remains unusually large.

Decision variableReported observationInvestor interpretation
Q2 revenue, ₹ crore133.256.7% below the unusually strong year-earlier quarter
Q2 EBITDA, ₹ crore31.454.1% lower year on year
H1 revenue, ₹ crore249.3A weak starting point for FY27 growth guidance
H1 operating cash flow, ₹ crore110.2Better than H1 net profit of ₹44 crore
Firm order book, ₹ crore1,723.6Contracted work, not current revenue
Negotiated but not received, ₹ crore956Exclude from firm orders until signed

The distinction between firm orders and negotiated awards is essential. Management's ₹2,698 crore visibility figure includes ₹956 crore of negotiated orders awaiting formal purchase orders. Counting the entire figure as irrevocable backlog would overstate near-term certainty. [S1] [S2]

  • Track signed purchase orders separately from negotiated opportunities.
  • Compare H2 deliveries with the full-year revenue guidance rather than extrapolating Q2.
  • Use cash conversion alongside reported EBITDA when evaluating the growth premium.

2. Q2 and H1 financials: the revenue decline is real, but the margin story is more nuanced

The investor presentation reports Q2 FY27 net revenue of ₹1,332 million against ₹3,075 million in Q2 FY26, a decline of 56.7%. Q1 FY27 revenue was ₹1,160 million, so sequential growth was 14.8%. H1 FY27 revenue of ₹2,493 million was 38.7% below the ₹4,068 million earned in H1 FY26. All these comparisons use the presentation's financial table; the same unit and period basis is maintained.

EBITDA was ₹314 million in Q2 FY27 versus ₹685 million a year earlier. Yet EBITDA margin increased from 22.3% to 23.6%, because revenue fell slightly faster than gross profit and the product/milestone mix changed. This is not proof of improved operating leverage: employee costs rose to ₹440 million from ₹379 million despite the lower revenue, and other expenses increased to ₹165 million from ₹121 million.

The Q2 gross margin of 69.0% was far higher than 38.5% a year earlier, but lower than 78.9% in Q1 FY27. Material cost and inventory movements make gross margin volatile in this project business. The investor should not treat a single quarter's gross margin as a stable product margin without understanding which large projects were delivered.

Presentation financials, ₹ millionQ2 FY26Q1 FY27Q2 FY27H1 FY26H1 FY27
Net revenue3,0751,1601,3324,0682,493
Gross profit1,1849159201,9771,835
EBITDA6853143141,006628
Profit before tax6642952951,003590
Net profit492221220747440
EBITDA margin, %22.327.023.624.725.2

Q2 reported profit after tax was ₹220 million, down 55.3% from ₹492 million. H1 PAT was ₹440 million against ₹747 million, down 41.1%. The presentation lists no exceptional item in these periods, so an adjusted-versus-statutory profit bridge is not required for a disclosed exceptional charge; however, the EBITDA used here is the issuer's presentation metric, not an independently reconstructed statutory subtotal.

A significant valuation issue is the gap between management's full-year 35–40% EBITDA margin guidance and the 25.2% achieved in H1. Stronger H2 deliveries would need to improve both the sales denominator and the product mix. It would be risky to apply the guided margin to all future revenue before the second-half results demonstrate that recovery. [S2]

  • Separate year-on-year decline from quarter-on-quarter recovery.
  • Watch employee costs as a percentage of revenue while engineering hiring continues.
  • Require a full-year margin bridge before treating 35–40% as normalized earnings.

3. Products and customer economics: the shift from parts to complete systems

Data Patterns designs and manufactures defence electronics across radars, electronic warfare, avionics, communications, satellite systems and test equipment. Its strategic shift is toward complete systems that combine proprietary electronic building blocks with integration, qualification and manufacturing. Larger contracts can increase revenue per program, but they also increase delivery responsibility and the risk of delays.

The H1 FY27 presentation shows radar representing 49.3% of the ₹17,236 million firm order book at September 30, 2026. Electronic warfare represented 17.7% and avionics 15.1%. These are order-book composition figures, not revenue shares or operating margins. A high radar concentration makes execution of a few sizeable defence programs disproportionately important.

Two Q2 radar production orders from Bharat Electronics were reported at ₹3,328 million and ₹2,530 million. Their combined ₹5,858 million is substantial relative to H1 recognized revenue of ₹2,493 million. But an order is not an invoice; manufacturing, testing, acceptance and customer milestones determine when the economics appear in the income statement.

The company also reported an international order book of ₹32 crore at September 30, 2026. Exports offer customer diversification, but the current amount is small compared with the domestic backlog. Management described new work in drone defence, radar warning receivers, jammers, advanced optronics and microsatellites. These are product-development directions, not separate disclosed profit pools.

The September 17, 2026 acquisition of ST Advanced Composites adds composite design and manufacturing capabilities. Its investment relevance is the potential to supply more of an integrated defence system internally. The available documents do not provide a separately quantified acquisition return or post-acquisition segment profit, so assigning an immediate earnings uplift would be premature. [S1] [S2]

  • Follow radar acceptance milestones because radar dominates firm orders.
  • Watch whether development contracts turn into repeat production orders.
  • Distinguish demonstrated exported products from future export opportunities.
  • Look for evidence that the composites acquisition raises contract value or lowers outsourced costs.

4. Execution and management Q&A: why the second half carries so much weight

Management said Q2 weakness reflected the unusually high execution base in the previous year and the timing of program milestones. Defence-electronics revenue is not evenly distributed across quarters; testing and acceptance can shift substantial sales between reporting dates. The company therefore expects H2 FY27 to be materially stronger than H1.

The strongest supporting indicator is order intake. Q2 FY27 inflows were ₹9,291 million versus ₹1,671 million in Q2 FY26, an increase of about 456% based on the reported amounts; the presentation separately highlights a large percentage increase. H1 inflows were ₹10,464 million versus ₹3,506 million a year earlier. These contracts improve forward visibility but do not eliminate delivery, collection or customer-approval risk.

In the analyst discussion, management explained that negotiated government contracts can take additional time to receive formal orders because of internal approval processes. It expected many of the pending awards within roughly one or two months, while also expressing confidence that the negotiated tenders would not be cancelled. That is management's assessment, not a contractual guarantee.

The company reported more than 1,100 engineers, with 1,137 as of September 2026 and 91 hired during Q2. This workforce is central to in-house product development and integration, but its cost is incurred before new programs produce revenue. The rise in employee expense despite weak Q2 sales illustrates the short-term earnings burden of capacity building.

The practical test of management's confidence is straightforward: signed orders must be followed by delivery, customer acceptance, invoices and cash. A growing backlog accompanied by repeated milestone slippage would weaken the investment case even if the technological opportunity remains attractive. [S1] [S2]

  • Check conversion of the ₹956 crore negotiated pipeline into signed orders.
  • Compare H2 revenue with the H1 ₹249.3 crore base.
  • Follow customer acceptance and dispatch dates, not only new tender announcements.
  • Monitor engineering cost growth relative to realized sales.

5. Cash, balance sheet and capital investment: stronger H1 conversion deserves attention

The presentation's H1 FY27 cash-flow statement reports ₹1,102 million of net cash from operating activities, compared with ₹440 million of net profit. Working-capital movements contributed ₹1,037 million, helping cash generation. This is encouraging, but the contribution may fluctuate as customer advances, inventory, milestone billings and receivables move through the project cycle.

The previous full financial year, FY26, generated ₹801 million of operating cash flow. H1 FY27 alone exceeded that amount. The contrast is meaningful, but six-month cash generation should not be annualized mechanically: milestone receipts and working-capital releases can be concentrated in particular periods.

The same H1 statement shows investing cash outflow of ₹361 million and financing cash outflow of ₹629 million. These are cash-flow categories, not a pure capex figure or a pure debt-repayment figure. Cash and cash equivalents at the end of H1 were ₹681 million, up from ₹568 million at the start of the financial year. Management separately referred to cash, bank balances and investments exceeding ₹500 crore; that broader liquidity definition should not be confused with the ₹68.1 crore cash-and-equivalents line.

The presentation states that roughly ₹190 crore was invested in capex over the preceding five years and that an additional ₹150 crore is planned over the next two years. It also states that more than ₹145 crore has been invested in new product development. Product development and physical capex are not interchangeable. Without project-level earnings or incremental cash-flow disclosures, the payback period on the planned spending cannot be measured reliably.

Cash-flow line, ₹ millionFY25FY26H1 FY27
Operating cash flow-8998011,102
Investing cash flow890-32-361
Financing cash flow-496-577-629
Ending cash equivalents376569681

The key question is whether positive cash conversion persists when revenue and procurement rise in H2. Larger production orders may demand inventory and testing expenditure before final customer payments. A temporary cash improvement is valuable; repeated positive operating cash flow through a growth cycle would justify greater confidence in earnings quality. [S2]

  • Reconcile cash equivalents with the broader cash-and-investments figure.
  • Track working-capital changes alongside order execution.
  • Separate planned ₹150 crore physical capex from product-development spending.
  • Seek evidence of incremental cash returns from the new manufacturing capacity.

6. Conditional outcomes: what would confirm or weaken the thesis

Bull case. The ₹956 crore negotiated pipeline converts to signed contracts, existing radar orders meet delivery milestones and H2 sales rebound strongly. A richer complete-system mix helps operating margin move toward management's 35–40% FY27 guidance. Cash receipts keep pace with deliveries, allowing the company to fund product development without a prolonged working-capital squeeze. The strongest confirmation would be simultaneous improvement in revenue, operating profit and cash conversion.

Base case. Signed orders support a multi-year pipeline, but the timing of customer acceptance keeps revenue uneven. H2 improves on H1 without fully delivering the guided annual growth and margin combination. Engineering expenses remain elevated as the company builds new product families. Under this outcome, the order book is strategically valuable but near-term earnings multiples should be based on realized rather than guided profits.

Bear case. Formal awards are delayed, a few large radar milestones slip into FY28 and H2 revenue remains too weak to absorb the expanded cost base. Margins stay near H1's 25.2% instead of reaching management's 35–40% target. Rising inventory or receivables reverses the H1 cash benefit. The share valuation could then face pressure even if headline order visibility remains high.

The cases are conditional paths, not probability-weighted forecasts. The evidence supports the direction of the risks but does not supply sufficient contracted delivery schedules, customer-wise cash terms or a market valuation input to calculate defensible scenario price targets.

A clear falsifier for the optimistic case would be another quarter with very strong order announcements but weak revenue conversion and worsening operating cash flow. A clear falsifier for the bearish case would be on-time H2 deliveries, rising margins and continued positive cash flow from operations. [S1] [S2]

  • Demand proof of order conversion before raising sustainable growth assumptions.
  • Treat management margin guidance as a testable target, not a reported margin.
  • Reassess concentration risk if a few radar programs dominate future deliveries.

7. Investor action plan: what to watch next

Current stance: WATCH. The order pipeline and domestic defence-electronics capabilities are attractive, but the September 2026 results do not yet demonstrate the earnings recovery required by management's FY27 outlook. The right near-term approach is to track contract conversion and the quality of H2 execution before assigning a stronger valuation premium.

At the next results announcement, begin with revenue and EBITDA rather than order intake alone. H1 revenue was ₹249.3 crore and H1 EBITDA was ₹62.8 crore, with a 25.2% margin. Those are the starting numbers against which the H2 recovery must be judged. A high full-year margin target requires a large second-half improvement, not simply a modest sequential uptick.

Next, review the status of ₹956 crore of negotiated but unsigned orders. Management suggested a short approval horizon during the Q2 call; a failure to convert them on that timeline would be an early signal to reduce confidence in the visibility figure. Conversely, signed orders should be tracked into manufacturing and customer acceptance, not counted twice as new economic value.

Then inspect operating cash flow and receivables. H1 operating cash flow of ₹110.2 crore was strong relative to ₹44 crore net profit, but the working-capital contribution may reverse when deliveries accelerate. Watch whether cash generation remains positive as the business scales.

Finally, assess the technology investments against tangible commercial milestones: new production awards, repeat orders, export wins, successful radar deliveries and evidence that the composites acquisition improves system economics. Product demonstrations and prospective opportunities matter, but sustained shareholder returns depend on delivered systems and collected cash.

MonitorQ2/H1 FY27 referenceWhat would change the view
H2 executionH1 revenue ₹249.3 croreLarge improvement in delivered and recognized revenue
ProfitabilityH1 EBITDA margin 25.2%Demonstrated recovery toward guided range
Signed pipeline₹956 crore negotiatedFormal orders received, without double counting
Cash qualityH1 operating cash flow ₹110.2 crorePositive cash flow despite production ramp
Order concentrationRadar 49.3% of firm backlogTimely radar milestones and broader program mix
Capital allocation₹150 crore planned two-year capexCommissioning and incremental productive utilization

Sources: [S1] ; [S2] . The transcript is an accepted derived-text source; the presentation is the issuer's original document. The financial and cash figures above use the presentation's reported periods and units, while future targets are explicitly management guidance.

Additional company evidence

CHART 5

H1 EBITDA

H1 FY26₹1,006 million
H1 FY27₹628 million
CHART 6

H1 net profit

H1 FY26₹747 million
H1 FY27₹440 million
CHART 7

EBITDA margin

Q2 FY2622.3%
Q1 FY2727%
Q2 FY2723.6%
CHART 8

Gross margin

Q2 FY2638.5%
Q1 FY2778.9%
Q2 FY2769%
SOURCE REFERENCES

Original disclosures and investor presentations

Original references are in the published manuscript below.

Related research and comparisons

Other published Q2 FY27 reports

This is dated research, not a live market quote. Scenarios and historical performance are not guarantees.